Normal Blood Sugar Levels in 2026
Blood sugar, or blood glucose, is one of the most closely watched numbers in modern health care, and for good reason: it sits at the center of how the body converts food into usable energy, and chronically elevated levels are the defining marker of both prediabetes and diabetes. Understanding what counts as a normal blood sugar level — and how that number shifts depending on whether you’ve just eaten, how old you are, and whether you already have a diagnosed condition — has become essential knowledge for a growing share of the population as diabetes and prediabetes rates continue climbing across the United States.
This report compiles the latest verified normal blood sugar level statistics for 2026, covering fasting and post-meal reference ranges, A1C benchmarks, age-specific targets from newborns through older adults, and the dangerous thresholds that signal a medical emergency. Every figure below reflects the clinical standards set by the American Diabetes Association (ADA) and reported by the Centers for Disease Control and Prevention (CDC), current through 2026. This information is intended for general reference and should not replace personalized guidance from a healthcare provider.
Interesting Facts About Blood Sugar Levels in 2026
Blood Sugar Reference Ranges: Fasting Glucose, 2026
Normal (70-99 mg/dL) |████████████████ |
Prediabetes (100-125 mg/dL) |████████████████████████ |
Diabetes (126+ mg/dL) |████████████████████████████ |
| Interesting Fact | 2026 Figure |
|---|---|
| Normal fasting blood sugar (no diabetes) | 70-99 mg/dL (3.9-5.5 mmol/L) |
| Prediabetes fasting range | 100-125 mg/dL (5.6-6.9 mmol/L) |
| Diabetes fasting threshold | 126 mg/dL or higher (confirmed by repeat testing) |
| Normal blood sugar 2 hours after eating | Below 140 mg/dL (7.8 mmol/L) |
| Normal A1C level | Below 5.7% |
| Americans currently living with diabetes | 40.1 million (12.0% of the population) |
| Americans currently living with prediabetes | 115.2 million adults (43%) |
| Adults with prediabetes who don’t know they have it | 8 in 10 |
Source: American Diabetes Association Clinical Practice Guidelines; CDC National Diabetes Statistics Report, January 2026
The baseline reference point for blood sugar is the fasting glucose test, taken after at least eight hours without food, and the ADA’s standard is unambiguous: a result between 70 and 99 mg/dL is considered normal for someone without diabetes. Move into the 100 to 125 mg/dL range and the result crosses into prediabetes, a category the CDC estimates now includes 115.2 million American adults — a striking 43% of the entire adult population. A fasting reading of 126 mg/dL or above, confirmed on a second separate test, meets the clinical threshold for a diabetes diagnosis.
What makes these numbers especially significant in 2026 is the awareness gap sitting behind them. Of the 40.1 million Americans currently living with diabetes, an estimated 11 million remain undiagnosed. The prediabetes figures are even starker: 8 in 10 adults with prediabetes don’t know they have the condition, meaning the vast majority of the 115.2 million people in that category are receiving no treatment or lifestyle guidance specifically targeted at reversing their trajectory toward type 2 diabetes — despite prediabetes being, in many cases, a reversible state with early intervention.
Normal Fasting Blood Sugar Levels by Age in 2026
Fasting Blood Sugar Ranges by Life Stage
Newborns |███ | 40-60 mg/dL
Children (up to 6) |████████ | 100-180 mg/dL (before eating)
Children/adolescents |███████ | 70-100 mg/dL (fasting, same as adults)
Adults (18-64) |███████ | 70-99 mg/dL
Adults (65+) |███████ | 70-99 mg/dL (target range widens with treatment)
| Age Group | Normal Fasting Range |
|---|---|
| Newborns | 40-60 mg/dL |
| Children up to age 6 (before eating) | 100-180 mg/dL (5.5-10 mmol/L) |
| Children and adolescents (fasting) | 70-100 mg/dL — same standard as adults |
| Adults 18-64 (no diabetes) | 70-99 mg/dL |
| Adults 65 and older (no diabetes) | 70-99 mg/dL, though treatment targets are often relaxed |
| ADA target for adults 65+ actively managing diabetes | 70-180 mg/dL |
Source: ADA Pediatric Clinical Guidelines; ADA Standards of Care in Diabetes, 2026
Blood sugar targets shift meaningfully across the human lifespan, and nowhere is that more apparent than at the two extremes. Newborns run considerably lower than adults, with normal readings typically falling between 40 and 60 mg/dL — a level that would be classified as dangerously low hypoglycemia in an adult but reflects normal newborn metabolism. Young children up to age 6 are held to a wider pre-meal target of 100 to 180 mg/dL, reflecting both their more erratic eating patterns and the greater physiological risk that tight glucose control carries for very young children. Once children reach school age, ADA pediatric guidelines converge on the same 70-100 mg/dL fasting standard used for adults.
At the other end of the age spectrum, normal, non-diabetic fasting glucose doesn’t actually change for adults over 65 — the 70-99 mg/dL range still applies. What does change is the treatment target for older adults who already have diagnosed diabetes: the ADA specifically recommends a wider, more relaxed target range of 70-180 mg/dL for many older adults managing diabetes, a deliberate trade-off that prioritizes avoiding dangerous hypoglycemic episodes — which carry heightened fall and cognitive risk in older patients — over the tighter glucose control targeted in younger, otherwise healthy adults.
Normal Blood Sugar Levels After Eating (Postprandial) in 2026
Post-Meal (2-Hour) Blood Sugar Reference Ranges
Normal (under 140 mg/dL) |████████████████ |
Prediabetes (140-199 mg/dL) |████████████████████████ |
Diabetes (200+ mg/dL) |████████████████████████████ || Category | 2-Hour Post-Meal Reading |
|---|---|
| Normal (no diabetes) | Below 140 mg/dL (7.8 mmol/L) |
| Prediabetes | 140-199 mg/dL (7.8-11.0 mmol/L) |
| Diabetes (via oral glucose tolerance test) | 200 mg/dL or higher |
| Young adults without diabetes, typical 2-hour reading | 90-110 mg/dL |
| Random blood sugar diabetes threshold (with symptoms) | 200 mg/dL or higher, any time of day |
Source: American Diabetes Association; Diabetes Self-Management Clinical Guidelines, March 2026
Blood sugar naturally rises after eating as the body breaks carbohydrates down into glucose, and the post-meal, or postprandial, reading taken roughly two hours after a meal offers a second, complementary window into glucose metabolism beyond the fasting test alone. For someone without diabetes, that two-hour reading should generally fall below 140 mg/dL; in fact, healthy young adults typically land in a considerably tighter range of just 90 to 110 mg/dL. A reading between 140 and 199 mg/dL indicates impaired glucose tolerance, the postprandial equivalent of prediabetes, while a result of 200 mg/dL or higher — confirmed via a formal oral glucose tolerance test — meets the clinical threshold for diabetes.
The post-meal test carries particular diagnostic value because some people maintain normal fasting glucose while still showing impaired tolerance after eating, a pattern that can be an earlier warning sign than fasting glucose alone. This is one reason the complete diabetes statistics and facts for the US show such a substantial gap between diagnosed and undiagnosed cases — postprandial glucose abnormalities can develop well before fasting numbers cross into clearly abnormal territory, meaning routine fasting-only screening can miss early metabolic dysfunction that a broader testing panel would catch.
A1C Levels and What They Mean in 2026
A1C Reference Ranges
Normal (under 5.7%) |████████████████ |
Prediabetes (5.7-6.4%) |████████████████████████ |
Diabetes (6.5%+) |████████████████████████████|
| A1C Category | Percentage |
|---|---|
| Normal | Below 5.7% |
| Prediabetes | 5.7% to 6.4% |
| Diabetes | 6.5% or higher |
| What A1C measures | Average blood sugar over the preceding 2-3 months |
| Standard ADA treatment target for most adults with diabetes | Below 7.0% |
| Adults with diabetes currently meeting that A1C target | Just over half, per national surveillance data |
Source: American Diabetes Association; CDC National Diabetes Statistics Report, 2026
The A1C test (also called hemoglobin A1C or HbA1c) works differently from fasting or post-meal glucose checks: rather than capturing a single-moment snapshot, it measures the percentage of hemoglobin proteins in the blood that have glucose attached to them, reflecting average blood sugar levels over the prior two to three months. That makes it the single most important long-term monitoring tool for anyone managing diabetes, since it smooths out the day-to-day and even hour-to-hour fluctuations that a fasting or post-meal check alone can’t capture. An A1C below 5.7% is considered normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or above meets the diagnostic threshold for diabetes.
For people already diagnosed with diabetes, the ADA generally recommends a treatment target of A1C below 7.0%, though — consistent with the age-based flexibility described earlier — that target is frequently individualized upward for older adults or anyone with a significant hypoglycemia risk, and downward for younger, otherwise healthy patients early in their diagnosis. National surveillance data shows that only about half of adults with diagnosed diabetes are currently meeting even the standard 7.0% target, underscoring that achieving consistent glucose control remains a genuine, ongoing challenge for a large share of the diabetic population rather than a one-time medical milestone.
Blood Sugar Targets for People With Diabetes in 2026
ADA Blood Sugar Targets for Adults With Diabetes
Before meals |████████████ | 80-130 mg/dL
1-2 hours after meals |████████████████████ | Under 180 mg/dL
Before sleep |██████████████████ | 110-200 mg/dL
Time in Range goal (CGM |██████████████████████████████████ | >70% within 70-180 mg/dL
| Timing | ADA Target (people with diabetes) |
|---|---|
| Before meals (preprandial) | 80-130 mg/dL |
| 1-2 hours after starting a meal (postprandial) | Below 180 mg/dL |
| Before sleep | 110-200 mg/dL |
| Continuous glucose monitor “Time in Range” goal | More than 70% of readings within 70-180 mg/dL |
| Target range for adults 65+ on treatment | 70-180 mg/dL, generally |
Source: American Diabetes Association Standards of Care, 2026
Once someone has a diabetes diagnosis, the reference ranges shift from the diagnostic thresholds described above to a distinct set of treatment targets designed to balance effective glucose control against the real risk of dangerously low blood sugar from medication. The ADA’s standard targets call for 80-130 mg/dL before meals and under 180 mg/dL one to two hours after eating — both notably higher than the strict “normal” ranges used to diagnose diabetes in the first place, reflecting the practical reality that people managing diabetes with insulin or other glucose-lowering medications need a safety margin to avoid hypoglycemia.
Continuous glucose monitors (CGMs), now widely used by both type 1 and type 2 diabetes patients, have introduced a newer, more nuanced metric called “Time in Range” (TIR) — the percentage of the day a person’s glucose stays within a target band, typically 70-180 mg/dL. The ADA and international diabetes consensus groups recommend a TIR goal of more than 70%, a benchmark that captures glucose variability and time spent dangerously low in a way that a single A1C percentage cannot. For a deeper look at how these targets play out specifically in type 2 diabetes — the form of the disease accounting for the vast majority of diagnosed cases — the full type 2 diabetes statistics for the US detail how glucose control targets intersect with the broader complications and healthcare utilization patterns tracked for this population.
Dangerous Blood Sugar Levels: Hypoglycemia and Hyperglycemia in 2026
Dangerous Blood Sugar Thresholds
Severe hypoglycemia (below 54 mg/dL) |████ |
Hypoglycemia (below 70 mg/dL) |████████ |
Normal range (70-99 fasting / <140 post)|████████████████ |
Dangerous hyperglycemia (300+ mg/dL) |████████████████████████████|
| Threshold | Clinical Significance |
|---|---|
| Below 54 mg/dL | Severe hypoglycemia — requires immediate treatment |
| Below 70 mg/dL | Hypoglycemia — dizziness, confusion, rapid heartbeat possible |
| Above 180 mg/dL, sustained | Hyperglycemia — associated with long-term complications if persistent |
| Above 300 mg/dL | Considered dangerous for people with or without diabetes; medical attention advised |
Source: American Diabetes Association; Healthline Clinical Review, 2026
Blood sugar readings outside the normal range aren’t just diagnostic markers — at the extremes, they represent genuine medical emergencies. Hypoglycemia, generally defined as a reading below 70 mg/dL, can produce symptoms including dizziness, confusion, sweating, and a rapid heart rate as the brain and body are starved of adequate glucose fuel. Readings that fall below 54 mg/dL are classified as severe hypoglycemia, a threshold at which immediate treatment — typically fast-acting carbohydrates or, in severe cases, emergency glucagon — becomes necessary to prevent loss of consciousness or seizure.
At the opposite extreme, sustained hyperglycemia carries its own serious risks. While the ADA’s day-to-day treatment targets aim to keep post-meal readings under 180 mg/dL, a reading climbing above 300 mg/dL is considered dangerous for people with or without a diabetes diagnosis and generally warrants prompt medical attention, since very high glucose levels can progress toward diabetic ketoacidosis or a hyperosmolar hyperglycemic state — both life-threatening complications requiring emergency care. This information is provided for general educational purposes; anyone experiencing symptoms of severe hypo- or hyperglycemia should seek immediate medical attention rather than relying on reference ranges alone.
Prediabetes and Diabetes Prevalence Statistics in 2026
US Diabetes and Prediabetes Prevalence, 2026
Diagnosed diabetes |████████████████ | 29.1 million
Undiagnosed diabetes |█████ | 11.0 million
Prediabetes |██████████████████████████| 115.2 million
| Prevalence Metric | 2026 Figure |
|---|---|
| Total Americans with diabetes (diagnosed + undiagnosed) | 40.1 million (12.0% of the population) |
| Diagnosed diabetes cases | 29.1 million |
| Undiagnosed diabetes cases | 11.0 million (27.6% of all diabetes cases) |
| Americans with prediabetes | 115.2 million adults (43%) |
| Diabetes prevalence, adults 65+ | 28.8% |
| Prediabetes prevalence, adults 65+ | 52.1% (31.3 million people) |
| People with diabetes worldwide (WHO estimate) | Over 800 million |
Source: CDC National Diabetes Statistics Report, January 2026; World Health Organization
The scale of abnormal blood sugar across the US population in 2026 is difficult to overstate: combining the 40.1 million Americans with diabetes and the 115.2 million with prediabetes means that well over half of American adults currently fall outside the normal glucose reference ranges described throughout this report. That burden climbs sharply with age — 28.8% of adults 65 and older already have diabetes, and 52.1% of that same age group has prediabetes, meaning more than 8 in 10 older Americans currently have blood sugar readings outside the normal range in one direction or another.
The growing prevalence of abnormal blood sugar has directly shaped the pharmaceutical and treatment landscape in 2026, most visibly through the rapid expansion of GLP-1 receptor agonist medications originally developed for diabetes management. The complete GLP-1 and Ozempic statistics report shows these medications reducing A1C levels by as much as 1.6 percentage points in clinical trials, and details how their use has expanded rapidly among both diagnosed diabetics and the broader at-risk population — a direct pharmaceutical response to the scale of glucose dysregulation captured in the prevalence statistics above.
Blood Sugar in Children and Special Populations in 2026
Blood Sugar Reference Ranges: Special Populations
Gestational diabetes — fasting |████████ | Under 95 mg/dL
Gestational diabetes — 1 hr post-meal |████████████████ | Under 180 mg/dL
Gestational diabetes — 2 hr post-meal |██████████████ | Under 153 mg/dL
Pediatric diabetes cases (under 20, US) |████ | ~352,000
| Population | Reference Standard |
|---|---|
| Gestational diabetes — fasting | Below 95 mg/dL |
| Gestational diabetes — 1-hour post-meal | Below 180 mg/dL |
| Gestational diabetes — 2-hour post-meal | Below 153 mg/dL |
| Diagnosed diabetes cases, Americans under 20 | ~352,000 |
| Of those, Type 1 diabetes cases | ~304,000 |
| Pediatric diabetes prevalence rate | 35 per 10,000 Americans under 20 |
Source: American College of Obstetricians and Gynecologists / ADA Gestational Diabetes Guidelines; CDC National Diabetes Statistics Report, 2026
Pregnancy introduces its own distinct set of blood sugar reference standards, since gestational diabetes — a form of diabetes that develops specifically during pregnancy — carries different diagnostic thresholds than standard adult glucose testing. Following an oral glucose tolerance test, the standard targets call for a fasting reading below 95 mg/dL, a 1-hour post-meal reading below 180 mg/dL, and a 2-hour post-meal reading below 153 mg/dL — tighter thresholds than general adult diabetes screening, reflecting how even modestly elevated glucose during pregnancy can affect fetal development and delivery outcomes.
Among children and adolescents specifically, roughly 352,000 Americans under age 20 currently have a diagnosed diabetes case, with the substantial majority — about 304,000 — living with type 1 diabetes, an autoimmune condition that typically requires lifelong insulin therapy from diagnosis onward. That translates to a pediatric prevalence rate of 35 cases per every 10,000 Americans under 20, a figure that, while far lower than adult prevalence rates, represents a population facing decades of glucose management ahead and a correspondingly higher lifetime risk of long-term complications if blood sugar isn’t kept within the target ranges outlined throughout this report.
Disclaimer: The data research report we present here is based on information found from various sources. We are not liable for any financial loss, errors, or damages of any kind that may result from the use of the information herein. We acknowledge that though we try to report accurately, we cannot verify the absolute facts of everything that has been represented.
